Skip to main content
    C

    Curis Inc (CRIS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.44
    -0.01 (-2.07%)

    Market Cap: $2.97M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Curis Inc (CRIS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Curis reported revenue of $9.44M for the fiscal year ended Dec 31, 2025, down 13.4% from the year before. That year, net income was -$7.58M with a net margin of -80.3%, operating cash flow was -$27.20M and free cash flow was -$27.20M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$8.12M.

    Revenue and Margins

    The operating margin was -60.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $7.53M, a compound annual rate of 2.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$9.44M-13.4%100.0%-60.5%-80.3%
    Dec 2024$10.91M+8.8%100.0%-408.3%-397.8%
    Dec 2023$10.02M-1.4%100.0%-482.2%-473.0%
    Dec 2022$10.16M-4.6%100.0%-521.7%-557.7%
    Dec 2021$10.65M-1.7%100.0%-395.0%-426.7%
    Dec 2020$10.84M+8.3%100.0%-229.8%-276.0%
    Dec 2019$10.00M-4.1%100.0%-243.5%-321.3%
    Dec 2018$10.43M+5.4%100.0%-281.3%-312.4%
    Dec 2017$9.90M+31.5%100.0%-502.7%-538.7%
    Dec 2016$7.53MN/A100.0%-771.1%-802.6%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$9.44M$10.91M$10.02M$10.16M$10.65M$10.84M$10.00M$10.43M$9.90M$7.53M
    Gross profit$9.44M$10.91M$10.02M$10.16M$10.65M$10.84M$10.00M$10.43M$9.90M$7.53M
    Research and development$28.25M$38.56M$39.50M$43.28M$34.88M$23.07M$22.30M$24.41M$45.10M$49.58M
    Operating income-$5.71M-$44.54M-$48.33M-$53.02M-$42.06M-$24.90M-$24.36M-$29.33M-$49.76M-$58.04M
    Net income-$7.58M-$43.39M-$47.41M-$56.67M-$45.44M-$29.91M-$32.14M-$32.58M-$53.32M-$60.41M
    EBITDA-$5.54M-$44.35MN/AN/A-$39.62M-$24.70M-$24.34M-$29.27M-$49.57M-$57.62M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$1.14M$3.18M$2.75M$2.38M$3.35M$2.93M$2.55M$2.09M$2.70M
    Gross profit$0$0$0$1.14M$3.18M$2.75M$2.38M$3.35M$2.93M$2.55M$2.09M$2.72M
    Operating income-$8.75M-$9.94M-$11.52M$19.62M-$6.92M-$8.25M-$10.16M-$8.99M-$10.57M-$12.51M-$12.47M-$12.20M
    Net income-$8.12M-$8.58M-$24.20M$19.36M-$7.73M-$8.59M-$10.62M-$9.62M-$10.09M-$11.80M-$11.88M-$11.71M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $1.19M by $3.87M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$19.97M$41.27M$77.28M$108.85M$162.30M$204.36M$35.11M$37.37M$73.80M$57.75M
    Current assets$6.92M$26.39M$60.91M$92.12M$122.38M$172.75M$25.00M$27.96M$64.29M$48.20M
    Cash and equivalents$5.06M$20.00M$26.68M$19.66M$40.01M$129.61M$15.43M$23.64M$38.29M$26.04M
    Total liabilities$14.50M$47.26M$57.61M$62.30M$71.59M$73.69M$69.02M$41.86M$49.80M$28.49M
    Short-term debt$1.19M$7.56M$8.50M$3.94M$682.00K$557.00K$0$6.88M$5.89M$4.94M
    Long-term debtN/AN/AN/AN/AN/A$334.00KN/A$28.60M$35.67M$14.92M
    Shareholder equity$5.46M-$6.00M$19.67M$46.55M$90.71M$130.67M-$33.91M-$4.50M$23.99M$29.27M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$18.80M$18.97M$29.69M$19.97M$27.64M$29.23M$39.33M$41.27M$42.47M$50.41M$62.02M$77.28M
    Total liabilities$16.25M$14.28M$16.98M$14.50M$42.33M$43.22M$45.93M$47.26M$51.21M$51.11M$52.56M$57.61M
    Cash and equivalents$5.01M$5.07M$15.00M$5.06M$9.05M$10.14M$20.28M$20.00M$20.85M$10.00M$29.96M$26.68M
    Shareholder equity$2.55M$4.70M$12.71M$5.46M-$14.69M-$13.99M-$6.61M-$6.00M-$8.73M-$694.00K$9.46M$19.67M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$27.20M-$39.56M-$38.43M-$54.34M-$37.62M-$25.74M-$26.20M-$30.07M-$48.35M-$35.81M
    Capital expenditures$0$0$416.00K$416.00K$0$677.00K$41.00K$85.00K$188.00K$329.00K
    Free cash flow-$27.20M-$39.56M-$38.85M-$54.75M-$37.62M-$26.42M-$26.25M-$30.15M-$48.54M-$36.14M
    Share repurchasesN/AN/AN/AN/AN/A$1.80M$0N/AN/AN/A
    Investing cash flow$2.50M$29.44M$37.79M$33.02M-$47.90M-$49.05M-$4.46M$21.37M-$3.63M$30.12M
    Financing cash flow$9.77M$3.44M$7.58M$867.00K-$4.17M$188.81M$23.27M-$5.96M$64.23M-$1.37M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$5.75M-$9.65M-$9.00M-$6.37M-$5.57M-$8.01M-$7.25M-$9.26M-$5.94M-$11.13M-$13.23M-$10.19M
    Free cash flowN/AN/A-$9.00M-$6.37M-$5.57M-$8.01M-$7.25M-$9.26M-$5.94M-$11.13M-$13.23M-$10.19M
    Last 12 quarters

    Frequently Asked Questions About CRIS

    What is Curis' annual revenue?

    Curis reported revenue of $9.44M for the fiscal year ended Dec 31, 2025.

    How fast is Curis' revenue growing?

    Revenue was down 13.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -2.4%.

    Is Curis profitable?

    No. Curis reported net income of -$7.58M for the fiscal year ended Dec 31, 2025, with a net margin of -80.3%.

    How much free cash flow does CRIS generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$27.20M minus capital expenditures of $0 produced free cash flow of -$27.20M.

    How much debt does Curis have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $1.19M and cash and equivalents of $5.06M.